Exportin 1‐mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma
Exportin 1 (XPO1) is the main nuclear export receptor that controls the subcellular trafficking and the functions of major regulatory proteins. XPO1 is overexpressed in various cancers and small inhibitors of nuclear export (SINEs) have been developed to inhibit XPO1. In primary mediastinal B‐cell l...
Main Authors: | Mélody Caillot, Hadjer Miloudi, Antoine Taly, Nuria Profitós‐Pelejà, Juliana C. Santos, Marcelo L. Ribeiro, Elsa Maitre, Simon Saule, Gaël Roué, Fabrice Jardin, Brigitte Sola |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-12-01
|
Series: | Molecular Oncology |
Subjects: | |
Online Access: | https://doi.org/10.1002/1878-0261.13386 |
Similar Items
-
Therapeutic Targeting of Exportin-1 in Childhood Cancer
by: Basia Galinski, et al.
Published: (2021-12-01) -
Management of Drug Resistance in Mantle Cell Lymphoma
by: Gaël Roué, et al.
Published: (2020-06-01) -
Selinexor, daratumumab, and dexamethasone in patients with relapsed or refractory multiple myeloma
by: Cristina Gasparetto, et al.
Published: (2021-02-01) -
Regulation of B-Cell Receptor Signaling and Its Therapeutic Relevance in Aggressive B-Cell Lymphomas
by: Núria Profitós-Pelejà, et al.
Published: (2022-02-01) -
<i>XPO1</i><sup>E571K</sup> Mutation Modifies Exportin 1 Localisation and Interactome in B-Cell Lymphoma
by: Hadjer Miloudi, et al.
Published: (2020-09-01)